Skip to main content
Premium Trial:

Request an Annual Quote

Court Dismisses Beckman Coulter From Digene's HPV IP Suit After Arbitration

NEW YORK (GenomeWeb News) — Digene today said that a federal court last week dismissed Beckman Coulter from a patent-infringement suit filed against it by Digene.
Digene sued Beckman and Ventana Medical Systems in 2005 for allegedly infringing patents related to the company’s human papillomavirus materials and intellectual property.
Digene said it will continue its litigation against Ventana.
Beckman Coulter and Digene agreed through arbitration in 2006 that Beckman’s sale of certain HPV-related patent rights to Ventana was “impermissible,” Digene CEO Daryl Faulkner said in a statement.
The court affirmed the decision of the arbitration panel, the Dispute Resolution of the American Arbitration Association, which found that Beckman Coulter violated a cross-license agreement between Digene and the Institut Pasteur by selling its HPV intellectual property to Ventana.
The panel also ruled that Beckman Coulter was allowed to assign HPV licenses it had received previously from Pasteur.
“With this motion behind us, we expect to continue our efforts to defend our intellectual property rights,” Faulkner said.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.